Researchers from University of California San Diego have found that two of the most frequently administered stem cell therapies, which are often used interchangeably, actually contain completely different types of cells. The results challenge the current “one-cell-cures-all” paradigm in orthopedic stem cell therapeutics and highlight the need for more informed and rigorous characterization of injectable stem cell therapies before they are marketed for use in patients.
A review of clinical features, diagnosis, and management of Mpox
A comprehensive review in JAMA outlines monkeypox’s clinical presentation and management, stressing the need for increased surveillance and vaccination efforts.
October 17, 2024